XML 72 R38.htm IDEA: XBRL DOCUMENT v3.26.1
STOCKHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2025
STOCKHOLDERS' EQUITY  
Schedule of share-based compensation expense

Share-based compensation expense for stock options and RSUs was as follows:

Years Ended

December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

Stock options

$

4,249,716

$

219,968

RSUs

 

2,831,989

 

348,620

Total share-based compensation expense

$

7,081,705

$

568,588

The following table summarizes the aggregate non-cash stock-based compensation recognized in the Consolidated Statement of Operations for stock options and RSUs:

Year Ended

December 31, 

  ​ ​ ​

2025

  ​ ​ ​

2024

General and administrative

$

633,799

$

363,195

Salaries and benefits

 

6,432,303

 

198,891

Professional fees

 

15,603

 

6,502

Total non-cash share-based compensation expense

$

7,081,705

$

568,588

Schedule of assumptions to value stock options

  ​ ​ ​

Year Ended

 

December 31, 

 

Weighted-Average Grant Date Assumptions

2025

 

Expected term (in years)

 

9.4

Risk-free interest rate

 

4.4

%

Expected dividend yield

 

%

Expected volatility

 

97.4

%

Fair value per share

$

2.53

Schedule of stock options activity

Weighted-

Weighted-

Average

Average

Exercise

Remaining

Aggregate

Price Per

Contractual

Intrinsic

  ​ ​ ​

Shares

  ​ ​ ​

Share

  ​ ​ ​

Term (in years)

  ​ ​ ​

Value

Options outstanding, December 31, 2024

 

4,330,000

$

0.23

 

3.7

$

6,652,700

Granted

 

2,431,582

 

2.50

 

 

Exercised

 

(951,667)

 

0.25

 

 

Forfeited

 

(174,167)

 

0.22

 

 

Expired

 

 

 

 

Options outstanding, December 31, 2025

 

5,635,748

$

1.21

 

5.5

$

21,526,399

Nonvested options, December 31, 2025

 

5,249,498

$

1.25

 

5.6

$

19,808,074

Vested and exercisable options, December 31, 2025

 

386,250

$

0.57

 

3.9

$

1,718,325

Schedule of restricted stock activity

Weighted-

Average

Grant Date

Fair Value

  ​ ​ ​

Shares

  ​ ​ ​

Per Share

RSUs outstanding at December 31, 2024

 

2,090,000

$

0.24

Granted

 

2,222,309

 

2.92

Vested

 

(1,443,198)

 

1.15

Forfeited

 

 

RSUs outstanding at December 31, 2025

 

2,869,111

$

1.86

Schedule of warrants outstanding

Following is a summary of the Company’s warrant activity in 2025 and 2024:

Weighted

Number of

Average

  ​ ​ ​

Warrants

  ​ ​ ​

Exercise Price

Balance at December 31, 2023

 

12,346,215

$

0.75

Exercised

(2,204,000)

0.67

Balance at December 31, 2024

10,142,215

0.77

Exercised

 

(7,308,322)

 

0.78

Balance at December 31, 2025

 

2,833,893

$

0.73

Each warrant represents the right to receive one share of the Company’s common stock. The composition of the Company’s warrants outstanding at December 31, 2025 was as follows:

Number of warrants

  ​ ​ ​

Exercise Price

  ​ ​ ​

Expiration Date

  ​ ​ ​

Remaining life (years)

857,143

$

0.46

 

1/27/2026

 

0.07

1,270,250

$

0.85

 

8/3/2026

 

0.59

706,500

$

0.85

 

2/1/2026

 

0.09

2,833,893

 

  ​

 

  ​

 

  ​